✦ LIBER ✦
Lower Baseline Prostate-specific Antigen Is Associated With a Greater Overall Survival Benefit From Sipuleucel-T in the Immunotherapy for Prostate Adenocarcinoma Treatment (IMPACT) Trial
✍ Scribed by Schellhammer, Paul F.; Chodak, Gerald; Whitmore, James B.; Sims, Robert; Frohlich, Mark W.; Kantoff, Philip W.
- Book ID
- 121958649
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 288 KB
- Volume
- 81
- Category
- Article
- ISSN
- 0090-4295
No coin nor oath required. For personal study only.